Original Research
2019 May;21(5):665-675.
JOURNAL：Eur J Heart Fail.
Article Link
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators.
KEYWORDS
protocol; heart failure; sodium-glucose co-transporter 2 inhibitor; type 2 diabetes mellitus
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
